ImmunoPrecise Antibodies Ltd. (OTCMKTS:IPATF – Get Free Report)’s stock price shot up 11% during mid-day trading on Tuesday . The stock traded as high as $1.97 and last traded at $1.71. 1,736,483 shares changed hands during trading, an increase of 8,443% from the average session volume of 20,327 shares. The stock had previously closed at $1.54.
ImmunoPrecise Antibodies Trading Up 11.0%
The company has a fifty day moving average of $1.23 and a 200-day moving average of $1.57.
ImmunoPrecise Antibodies Company Profile
ImmunoPrecise Antibodies Ltd (OTCMKTS:IPATF) is a Canada-based contract research organization specializing in the discovery and development of therapeutic antibodies. The company provides a full suite of preclinical research services, from target validation and lead identification through to humanization and optimization. Its capabilities encompass hybridoma, phage display, single B cell sorting and next-generation sequencing platforms to accelerate antibody candidate selection and characterization.
ImmunoPrecise serves biopharmaceutical and biotechnology partners worldwide, offering customized solutions for projects in immuno-oncology, infectious diseases, autoimmunity and other therapeutic areas.
See Also
- Five stocks we like better than ImmunoPrecise Antibodies
- Banks Are Buying Back Stock Hand Over Fist, Including These 3 Names
- 2 Aluminum Stocks Poised for Big Tariff-Related Gains
- AutoZone’s Pullback Sets Up a Long-Term Buying Opportunity
- AST SpaceMobile’s June Launch Plan Puts Its 2026 Satellite Goal Back in Focus
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
